52
Views
10
CrossRef citations to date
0
Altmetric
Original

Changing structure and resources in a rheumatology combined unit during 1977–1999

, , &
Pages 125-135 | Accepted 07 Jul 2006, Published online: 12 Jul 2009

References

  • Pincus T., Callahan L. F., Sale W. G., Brooks A. L., Payne L. E., Vaughn W. K. Severe functional declines, work disability, and increased mortality in seventy‐five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864–72
  • Wolfe F., Mitchell D. M., Sibley J. T., Fries J. F., Bloch D. A., Williams C. A., et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481–94
  • Ward M. M., Fries J. F. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981–1996. J Rheumatol 1998; 25: 408–16
  • Wolfe F., Zwillich S. H. The long‐term outcomes of rheumatoid arthritis: a 23‐year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1072–82
  • Hakala M., Nieminen P., Koivisto O. More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol 1994; 21: 1432–7
  • Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
  • Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–45
  • Felson D. T., Anderson J. J., Boers M., Bombardier C., Furst D., Goldsmith C., et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727–35
  • van der Heijde D. M. F. M., van't Hof M. A., van Riel P. L. C. M., Theunisse L. A. M., Lubberts E. W., van Leeuwen M. A., et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916–20
  • van Riel P. L., van Gestel A. M., van de Putte L. B. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996; 35 Suppl 2: 4–7
  • Paulus H. E., Egger M. J., Ward J. R., Williams H. J. Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum 1990; 33: 477–84
  • Bellamy N., Kaloni S., Pope J., Coulter K., Campbell J. Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. J Rheumatol 1998; 25: 852–8
  • Stone C. E. The lifetime economic costs of rheumatoid arthritis. J Rheumatol 1984; 11: 819–27
  • Wolfe F., Kleinheksel S. M., Spitz P. W., Lubeck D. P., Fries J. F., Young D. Y., et al. A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical–surgical admissions, and charges. Arthritis Rheum 1986; 29: 614–19
  • Jonsson B., Larsson S. E. Functional improvement and costs of hip and knee arthroplasty in destructive rheumatoid arthritis. Scand J Rheumatol 1991; 20: 351–7
  • Yelin E. Arthritis: the cumulative impact of a common chronic condition. Arthritis Rheum 1992; 35: 489–97
  • Yelin E., Callahan L. F., for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 1351–62
  • Sowden A., Aletras V., Place M., Rice N., Eastwood A., Grilli R., et al. Volume of clinical activity in hospitals and healthcare outcomes, costs, and patient access. Qual Health Care 1997; 6: 109–14
  • Lanes S. F., Lanza L. L., Radensky P. W., Yood R. A., Meenan R. F., Walker A. M., et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997; 40: 1475–81
  • Kobelt G., Eberhardt K., Jonsson L., Jonsson B. Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum 1999; 42: 347–56
  • Hansagi H., Allebeck P., Allander E. Utilization of hospital care among persons with rheumatoid arthritis compared with controls. Scand J Rheumatol 1985; 14: 403–10
  • Sorensen J. Health care costs attributable to the treatment of rheumatoid arthritis. Scand J Rheumatol 2004; 33: 399–404
  • Gabriel S. E., Crowson C. S., Campion M. E., O'Fallon W. M. Direct medical costs unique to people with arthritis. J Rheumatol 1997; 24: 719–25
  • Soderlin M. K., Kautiainen H., Jonsson D., Skogh T., Leirisalo‐Repo M. The cost of early inflammatory joint disease: a population‐based study in southern Sweden. Scand J Rheumatol 2003; 32: 216–24
  • Yelin E., Wanke L. A. An assessment of the annual and long‐term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum 1999; 42: 1209–18
  • Kobelt G., Lindgren P., Lindroth Y., Jacobson L., Eberhardt K. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 1169–75
  • Pugner K. M., Scott D. I., Holmes J. W., Hieke K. The cost of rheumatoid arthritis: an international long‐term view. Semin Arthritis Rheum 2000; 29: 305–20
  • Albers J. M. C., Kuper H., van Riel P. L. C. M., Prevoo M. L. L., Van't Hof M. A., van Gestel A. M., et al. Socio‐economic consequences of rheumatoid arthritis in the first years of the disease. Rheumatology 1999; 38: 423–30
  • Soderlin M. K., Kautiainen H., Skogh T., Leirisalo‐Repo M. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden. J Rheumatol 2004; 31: 1717–22
  • Jonsson D., Husberg M. Socioeconomic costs of rheumatic diseases. Implications for technology assessment. Int J Technol Assess Health Care 2000; 16: 1193–200
  • Michaud K., Messer J., Choi H. K., Wolfe F. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three‐year study of 7,527 patients. Arthritis Rheum 2003; 48: 2750–62
  • Kvalvik A. G., Aadland H. A., Høyeraal H. M., Larsen S. Were the patterns of treatment for rheumatoid arthritis during 1977–1992 consistent with modern clinical guidelines?. Scand J Rheumatol 2001; 30: 61–8
  • Kvalvik A. G., Jones M. A., Symmons D. P. M. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 2000; 29: 29–37
  • Glader E. L. A national quality registry shows differences when it comes to stroke care [in Swedish]. Lakartidningen 2004; 101: 370–5
  • Clarke A. E., Esdaile J. M., Hawkins D. Inpatient rheumatic disease units: are they worth it?. Arthritis Rheum 1993; 36: 1337–40
  • Ward M. M. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 891–8
  • Ahlmén A., Sullivan M., Bjelle A. Team versus non‐team outpatient care in rheumatoid arthritis. A comprehensive outcome evaluation including overall health measure. Arthritis Rheum 1988; 31: 471–9
  • de Croon E. M., Sluiter J. K., Nijssen T. F., Kammeijer M., Dijkmans B. A., Lankhorst G. J., et al. Work ability of Dutch employees with rheumatoid arthritis. Scand J Rheumatol 2005; 34: 277–83
  • Jacobsson L. T., Frithiof M., Olofsson Y., Runesson I., Strombeck B., Wikstrom I. Evaluation of a structured multidisciplinary day care program in rheumatoid arthritis. A similar effect in newly diagnosed and long‐standing disease. Scand J Rheumatol 1998; 27: 117–24
  • Ahlmén M., Bjelle A., Sullivan M. Prediction of team care effects in outpatients with rheumatoid arthritis. J Rheumatol 1991; 18: 1655–61
  • MacLean C. H., Saag K. G., Solomon D. H., Morton S. C., Sampsel S., Klippel J. H. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004; 51: 193–202
  • Khanna D., Arnold E. L., Pencharz J. N., Grossman J. M., Traina S. B., Lal A., et al. Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. Semin Arthritis Rheum 2006; 35: 211–37
  • Girard F., Guillemin F., Novella J. L., Valckenaere I., Krzanowska K., Vitry F., et al. Health‐care use by rheumatoid arthritis patients compared with non‐arthritic subjects. Rheumatology (Oxford) 2002; 41: 167–75
  • Jacobi C. E., Triemstra M., Rupp I., Dinant H. J., Van den Bos G. A. M. Health care utilization among rheumatoid arthritis patients referred to a rheumatology center: unequal needs, unequal care?. Arthritis Rheum 2001; 45: 324–30
  • Ward M. M. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980–1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol 1999; 26: 546–50
  • Kremers H. M., Nicola P., Crowson C. S., O'Fallon W. M., Gabriel S. E. Therapeutic strategies in rheumatoid arthritis over a 40‐year period. J Rheumatol 2004; 31: 2366–73
  • Welsing P. M., Fransen J., van Riel P. L. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005; 52: 2616–24
  • Bergstrom U., Book C., Lindroth Y., Marsal L., Saxne T., Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999; 28: 160–5
  • Bjornadal L., Baecklund E., Yin L., Granath F., Klareskog L., Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964–95. J Rheumatol 2002; 29: 906–12
  • Silman A., Davies P., Currey H. L., Evans S. J. Is rheumatoid arthritis becoming less severe?. J Chronic Dis 1983; 36: 891–7
  • Symmons D., Turner G., Webb R., Asten P., Barrett E., Lunt M., et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002; 41: 793–800
  • Doran M. F., Pond G. R., Crowson C. S., O'Fallon W. M., Gabriel S. E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year period. Arthritis Rheum 2002; 46: 625–31
  • Uhlig T., Kvien T. K. Is rheumatoid arthritis disappearing?. Ann Rheum Dis 2005; 64: 7–10
  • Silman A. J. The changing face of rheumatoid arthritis: why the decline in incidence?. Arthritis Rheum 2002; 46: 579–81
  • Symmons D. P. Looking back: rheumatoid arthritis – aetiology, occurrence and mortality. Rheumatology (Oxford) 2005; 44 Suppl 4: iv14–17
  • Emery P. Vision of the future in arthritis care. Scand J Rheumatol Suppl 1999; 28: 3–11
  • Pincus T., Gibofsky A., Weinblatt M. E. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 2002; 46: 851–4
  • Mitchell K. Shared care – the way forward for patient‐orientated follow‐up care in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 457–8
  • Hill J. The expanding role of the nurse in rheumatology. Br J Rheumatol 1997; 36: 410–12
  • Harrington J. T., Walsh M. B. Pre‐appointment management of new patient referrals in rheumatology: a key strategy for improving health care delivery. Arthritis Rheum 2001; 45: 295–300
  • Hewlett S., Mitchell K., Haynes J., Paine T., Korendowych E., Kirwan J. R. Patient‐initiated hospital follow‐up for rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 990–7
  • Hurst N. P., McRorie E. R. The short‐term health outcome of out‐patient rheumatology consultations in relation to rationing: a pilot study. Br J Rheumatol 1998; 37: 509–13
  • Gran J. T., Nordvag B. Y. Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol 2000; 19: 450–4
  • Hootman J. M., Helmick C. G., Schappert S. M. Magnitude and characteristics of arthritis and other rheumatic conditions on ambulatory medical care visits, United States, 1997. Arthritis Rheum 2002; 47: 571–81
  • Brage S., Tellnes G. ICPC in general practice [in Norwegian]. Tidsskr Nor Lægeforen 1992; 112: 2656–9
  • Sokka T., Möttönen T., Hannonen P. Disease‐modifying anti‐rheumatic drug use according to the ‘sawtooth’ treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long‐term follow‐up study with review of the literature. Rheumatology (Oxford) 2000; 39: 34–42
  • Mõttõnen T., Hannonen P., Korpela M., Nissilã M., Kautiainen H., Ilonen J., et al. Delay to institution of therapy and induction of remission using single‐drug or combination‐disease‐modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46: 894–8
  • Korpela M., Laasonen L., Hannonen P., Kautiainen H., Leirisalo‐Repo M., Hakala M., et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: five‐year experience from the FIN‐RACo study. Arthritis Rheum 2004; 50: 2072–81
  • Karjalainen K., Malmivaara A., van Tulder M., Roine R., Jauhiainen M., Hurri H., et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev 2000; (2), CD001984
  • Miedema H. S., Van der Linden S. M., Rasker J. J., Valkenburg H. A. National database of patients visiting rheumatologists in the Netherlands: The standard diagnosis register of rheumatic diseases. A report and preliminary analysis. Br J Rheumatol 1998; 37: 555–61
  • Kirwan J. R., Averns H., Creamer P., Davies M., Hickling P., Hutton C., et al. Changes in rheumatology out‐patient workload over 12 years in the South West of England. Rheumatology (Oxford) 2003; 42: 175–9
  • Gamez‐Nava J. I., Gonzalez‐Lopez L., Davis P., Suarez‐Almazor M. E. Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol 1998; 37: 1215–19
  • Fraser I. AHRQ quality indicators – Guide to inpatient quality indicators: quality of care in hospitals – volume, mortality, and utilization, Rockville, MD: Department of Health and Human Services, Agency for Healthcare Research and Quality, 2002. Revision 2, 2003
  • Sowden A., Grilli R., Rice N. The relationship between hospital volume and quality of health outcomes, York, UK: NHS Centre for Reviews and Dissemination, University of York, 1997. CRD Report 8, Part 1
  • Teisberg P., Hansen F. H., Hotvedt R., Ingebrigtsen T., Kvalvik A. G., Lund E., et al. Hospital volume and quality health outcomes, Oslo: The Norwegian Centre for Health Technology Assessment, Sintef Unimed; 2001. Report no. 82‐14‐02407‐2
  • Halm E. A., Lee C., Chassin M. R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002; 137: 511–20
  • Espehaug B., Havelin L. I., Engesæter L. B., Vollset S. E. The effect of hospital‐type and operating volume on the survival of hip replacements. A review of 39,505 primary total hip replacements reported to the Norwegian Arthroplasty Register, 1988–1996. Acta Orthop Scand 1999; 70: 12–18
  • Norton E. C., Garfinkel S. A., McQuay L. J., Heck D., Wright J. G., Dittus R., et al. The effect of hospital volume on the in‐hospital complication rate in knee replacement patients. Health Serv Res 1998; 33: 1191–210
  • Katz J. N., Barrett J., Mahomed N. N., Baron J. A., Wright R. J., Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 2004; 86‐A: 1909–16
  • Jain N., Pietrobon R., Hocker S., Guller U., Shankar A., Higgins L. D. The relationship between surgeon and hospital volume and outcomes for shoulder arthroplasty. J Bone Joint Surg Am 2004; 86‐A: 496–505
  • Hammond J. W., Queale W. S., Kim T. K., McFarland E. Surgeon experience and clinical outcomes for shoulder arthroplasties. J Bone Joint Surg Am 2003; 85A: 2318–24
  • American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46: 328–46

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.